TICK-BORNE ENCEPHALITIS VACCINE MARKET SIZE, SHARE & TRENDS ANALYSIS REPORT FORECAST 2024 2031

Tick-Borne Encephalitis Vaccine Market Size, Share & Trends Analysis Report Forecast 2024 2031

Tick-Borne Encephalitis Vaccine Market Size, Share & Trends Analysis Report Forecast 2024 2031

Blog Article

The global tick-borne encephalitis vaccine market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Tick-borne encephalitis vaccine is used against tick-borne encephalitis virus, which spread by bites of virus-infected ticks, affecting the brain and spinal cord. The major symptoms that result due to tick-borne encephalitis infection include high temperature (fever), agitation, headache, sickness (vomiting), and confusion. The major factors that drive the growth of the market include the surge in prevalence of tick-borne encephalitis, particularly in Europe, and increased government funding on healthcare facilities. In addition, an increase in drug development fuels market growth.

Get Sample Copy of this Report at

https://www.omrglobal.com/request-sample/tick-borne-encephalitis-vaccine-market

As per the geographical analysis, the cases of this infection are growing quickly and is largely being registered in several parts of Asia and Europe. The highest number of cases occurs in Russia. This rise in the number of cases is driving the growth of the Tick-borne Encephalitis Vaccine Market. However, the high cost of vaccines is the major restraint of the market. On the contrary, untapped economies with unmet medical needs are anticipated to provide lucrative opportunities for market growth.

Some key players operating in the market include copyright Inc., GlaxoSmithKline plc, and Baxter International Inc., among others. The market players are adopting several strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. For instance, in February 2021, copyright declared that the US FDA has granted a fast review for TicoVac tick-borne encephalitis (TBE) vaccine, to prevent the disease in individuals one year of age or older. If approved TicoVac would be the first shot to support protect adults and children who are visiting or living in areas where TBE is endemic.
Competitive Landscape: copyright Inc., GlaxoSmithKline plc, and Baxter International Inc., among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?
Global Tick-Borne Encephalitis Vaccine Market Report by Segment

By Virus Type

European TBE Virus
Far Eastern TBE Virus
Siberian TBE Virus
By Application

Pediatric
Adult
Traveler

Inquire for Discount on this Report at

https://www.omrglobal.com/report-customization/tick-borne-encephalitis-vaccine-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404

Report this page